Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2036583 | 0.90 | TSHR (0.38) | TSHRLMNATDP1POLBAPEX1 | |
| SCHEMBL9145562 | 0.85 | TDP1 (0.36) | TSHRLMNATDP1HTTADRB2 | |
| SCHEMBL14382215 | 0.84 | TDP1 (0.36) | TSHRLMNATDP1POLBAPEX1 | |
| SCHEMBL2679520 | 0.83 | GPR174 (0.36) | TDP1ABCB1PLA2G2ABLM | |
| SCHEMBL10932059 | 0.83 | TSHR (0.42) | TSHRLMNATDP1POLBAPEX1 | |
| SCHEMBL17678830 | 0.81 | TSHR (0.39) | TSHRLMNATDP1POLBAPEX1 | |
| SCHEMBL14409178 | 0.81 | THRB (0.40) | TSHRLMNATDP1POLBADRB2 | |
| SCHEMBL28559612 | 0.80 | POLB (0.46) | TSHRLMNAPOLBABCB1 | |
| SCHEMBL22493862 | 0.79 | TSHR (0.33) | TSHRLMNATDP1POLBAPEX1 | |
| SCHEMBL4102932 | 0.79 | LMNA (0.35) | LMNATDP1ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 498 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250017827-A1 | Acid-Stable Glass Fillers And Self-Adhesive Dental Composite Cements With Good Transparency Containing Them | IVOCLAR VIVADENT AG (LI) | 2025-01-16 | — | — | US | claimed |
| EP-4488243-A1 | ACID-STABLE GLASS FILLERS AND SELF-ADHESIVE DENTAL COMPOSITE CEMENTS CONTAINING SAME HAVING GOOD TRANSPARENCY | Ivoclar Vivadent AG (LI) | 2025-01-08 | — | — | EP | claimed |
| US-20240158614-A1 | STORAGE STABLE SELF-ADHESIVE COMPOSITE CEMENTS WITH GOOD TRANSPARENCY AND GOOD RADIOPACITY | IVOCLAR VIVADENT AG (LI) | 2024-05-16 | — | — | US | claimed |
| EP-4356893-A1 | STORAGE STABLE SELF-ADHESIVE COMPOSITE CEMENTS WITH GOOD TRANSPARENCY AND GOOD RADIOPACITY | Ivoclar Vivadent AG (LI) | 2024-04-24 | — | — | EP | claimed |
| CN-117917236-A | Storage-stable self-adhesive composite cements with good transparency and good radiopacity | 义获嘉伟瓦登特公司 | 2024-04-23 | — | — | CN | claimed |
| US-20240099942-A1 | RADICALLY POLYMERIZABLE COMPOSITION COMPRISING A REDOX INITIATOR SYSTEM BASED ON DIHYDROPYRIDINES | IVOCLAR VIVADENT AG (LI) | 2024-03-28 | — | — | US | claimed |
| EP-4331557-A1 | RADICALLY POLYMERIZABLE COMPOSITION COMPRISING A REDOX INITIATOR SYSTEM BASED ON DIHYDROPYRIDINES | Ivoclar Vivadent AG (LI) | 2024-03-06 | — | — | EP | claimed |
| EP-4205723-A1 | HIGH TRANSPARENCY, SULPHATE-CONTAINING OR PHOSPHATE-CONTAINING DENTAL SELF-ADHERING COMPOSITE | Ivoclar Vivadent AG (LI) | 2023-07-05 | — | — | EP | claimed |
| EP-4205724-A1 | SELF-ADHESIVE DENTAL COMPOSITE CEMENTS WITH GOOD TRANSPARENCY BASED ON ACID-TREATED FILLERS | Ivoclar Vivadent AG (LI) | 2023-07-05 | — | — | EP | claimed |
| EP-4205722-A1 | SELF-ADHESIVE DENTAL COMPOSITE WITH GOOD TRANSPARENCY | Ivoclar Vivadent AG (LI) | 2023-07-05 | — | — | EP | claimed |
| EP-2578201-A1 | Dental materials with improved hydrolysis stability on the basis of phthalic acid monomers | Ivoclar Vivadent AG (LI) | 2013-04-10 | — | — | EP | claimed |
| WO-2013034778-A2 | DENTAL MATERIALS BASED ON COMPOUNDS HAVING DEBONDING-ON-DEMAND PROPERTIES | IVOCLAR VIVADENT AG (LI) | 2013-03-14 | — | — | WO | claimed |
| WO-2013034777-A2 | DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES | IVOCLAR VIVADENT AG (LI) | 2013-03-14 | — | — | WO | claimed |
| EP-2226061-B1 | Infiltrant for dental application | MUEHLBAUER ERNST GMBH & CO KG (DE) | 2012-12-26 | — | — | EP | claimed |
| EP-2226061-A1 | Infiltrant for dental application | Ernst Mühlbauer GmbH & Co.KG (DE) | 2010-09-08 | — | — | EP | claimed |
| US-7714034-B2 | Photopolymerizable dental materials with bisacylphosphine oxides as initiators | IVOCLAR VIVADENT AG (LI) | 2010-05-11 | — | — | US | claimed |
| EP-1749513-B1 | Photopolymerisable dental material with bisacylphosphine oxides as initiator | IVOCLAR VIVADENT AG (LI) | 2009-03-04 | — | — | EP | claimed |
| EP-1749513-A1 | Photopolymerisable dental material with bisacylphosphine oxides as inhibitors | Ivoclar Vivadent AG (LI) | 2007-02-07 | — | — | EP | claimed |
| US-20070027229-A1 | Photopolymerizable dental materials with bisacylphosphine oxides as initiators | IVOCLAR VIVADENT AG (LI) | 2007-02-01 | — | — | US | claimed |
| US-4373035-A | Isotonic monomer formulations | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1983-02-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240099942-A1 | RADICALLY POLYMERIZABLE COMPOSITION COMPRISING A REDOX INITIATOR SYSTEM BASED ON DIHYDROPYRIDINES | TAS1R1, TAS2R1, TAS2R41 | TSHR 4092/4885LMNA 3743/4885TDP1 89/4885 |
| US-20250017827-A1 | Acid-Stable Glass Fillers And Self-Adhesive Dental Composite Cements With Good Transparency Containing Them | HAO2, HAO1, CDH1 | TSHR 4061/4885LMNA 2791/4885TDP1 3608/4885 |
| US-20070027229-A1 | Photopolymerizable dental materials with bisacylphosphine oxides as initiators | PRXL2A, PGM2, PAM | TSHR 1818/4885LMNA 913/4885TDP1 2404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.